Tough questions, few answers: The FDA wrestles with its approach to AI in medicine
EXCERPT FROM THE ARTICLE
Related news
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.